Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer

Benedikt Gröschl1, Marcus Bettstetter, Christian Giedl

  • 1Institute of Pathology and Molecular Pathology Diagnostic Unit, University of Regensburg, Germany.

Insights

DUSP4 (dual specificity phosphatase 4) is overexpressed in microsatellite instability-high colorectal cancer (MSI-H CRC), driving increased cell growth by regulating MAPK pathways. This suggests DUSP4 is a key factor in MSI-H CRC progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Mitogen-activated protein kinase phosphatases (MKPs), including DUSP4 (MKP-2), are critical regulators of mitogen-activated protein kinases (MAPKs).
  • MAPKs are integral to cancer development and progression.
  • Previous microarray studies indicated DUSP4 overexpression in microsatellite instability-high (MSI-H) colorectal cancer (CRC) compared to microsatellite-stable (MSS) CRC.

Purpose of the Study:

  • To investigate DUSP4 mRNA expression levels in MSI-H and MSS CRC.
  • To explore the regulatory mechanisms of DUSP4 expression, including promoter methylation and mutations.
  • To determine the functional impact of DUSP4 overexpression on MAPK signaling and cell proliferation in CRC.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) to assess DUSP4 mRNA expression in 38 CRC tumors (19 MSI-H, 19 MSS) and matched normal tissues.
  • Analysis of DUSP4 promoter methylation using quantitative methylation analysis.
  • Genomic DNA sequencing to detect DUSP4 mutations in CRC cell lines.
  • DUSP4 transfection experiments in CRC cell lines to evaluate effects on MAPK target gene expression and cell proliferation.

Main Results:

  • DUSP4 was significantly overexpressed in MSI-H CRC tumors compared to MSS CRC tumors (p < 0.001).
  • MSI-H CRC cell lines exhibited substantially higher DUSP4 mRNA levels (6.8-fold) than MSS cell lines.
  • DUSP4 expression was not linked to promoter methylation or mutations.
  • DUSP4 overexpression upregulated MAPK target genes (CDC25A, CCND1, EGR1, FOS, MYC, CDKN1A) and downregulated MSH2, leading to increased CRC cell proliferation.

Conclusions:

  • DUSP4 is a key regulator of cell growth within the MAPK pathway in CRC.
  • DUSP4 overexpression contributes to enhanced cell growth in MSI-H CRC.
  • The findings highlight DUSP4 as a potential therapeutic target in MSI-H CRC.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...